Entering text into the input field will update the search result below

Watson Pharmaceuticals (WPI) expects to close its $5.9B acquisition of Swiss peer Actavis by...

Oct. 16, 2012 8:14 AM ETAllergan plc (AGN) StockAGN, PRXBy: Yigal Grayeff, SA News Editor

Watson Pharmaceuticals (WPI) expects to close its $5.9B acquisition of Swiss peer Actavis by early November after it yesterday received FTC permission for the deal, adding to EU authorization earlier this month. Under the conditions of the approval, Watson must sell 14 generic drugs to Par Pharmaceuticals (NYSE:PRX) and four to Sandoz. (PR)

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
AGN--
Allergan plc
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.